Canaan (CAN) had the highest return between December 13, 2023 and December 20, 2023 by a small-cap US stock, returning 108.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Canaan (CAN) | 12/13/2023 - 12/20/2023 | 108.94% |
Loandepot (LDI) | 12/13/2023 - 12/20/2023 | 65% |
Waldencast Acquisition (WALDW) | 12/13/2023 - 12/20/2023 | 63.33% |
Cipher Mining (CIFR) | 12/13/2023 - 12/20/2023 | 62.29% |
ZimVie (ZIMV) | 12/13/2023 - 12/20/2023 | 60% |
Oncology Institute (TOI) | 12/13/2023 - 12/20/2023 | 57.14% |
Esperion Therapeutics (ESPR) | 12/13/2023 - 12/20/2023 | 53.38% |
Wheels Up Experience (UP) | 12/13/2023 - 12/20/2023 | 45.45% |
Gyre Therapeutics (GYRE) | 12/13/2023 - 12/20/2023 | 44.22% |
OPTIMIZERx (OPRX) | 12/13/2023 - 12/20/2023 | 42.73% |
Neonode (NEON) | 12/13/2023 - 12/20/2023 | 40.34% |
NRx Pharmaceuticals (NRXPW) | 12/13/2023 - 12/20/2023 | 40% |
Blade Air Mobility (BLDEW) | 12/13/2023 - 12/20/2023 | 37.47% |
Finance of America Companies (FOA) | 12/13/2023 - 12/20/2023 | 34.65% |
Intrepid Potash (IPI) | 12/13/2023 - 12/20/2023 | 34.48% |
Altimmune (ALT) | 12/13/2023 - 12/20/2023 | 34.12% |
SolarEdge Technologies (SEDG) | 12/13/2023 - 12/20/2023 | 32.64% |
Blue Ridge Bankshares (BRBS) | 12/13/2023 - 12/20/2023 | 31.8% |
4D Molecular Therapeutics (FDMT) | 12/13/2023 - 12/20/2023 | 31.65% |
Absci (ABSI) | 12/13/2023 - 12/20/2023 | 30.77% |
Worthington Steel (WS) | 12/13/2023 - 12/20/2023 | 28.9% |
Community Health Systems (CYH) | 12/13/2023 - 12/20/2023 | 28.87% |
Byrna Technologies (BYRN) | 12/13/2023 - 12/20/2023 | 28.74% |
Porch (PRCH) | 12/13/2023 - 12/20/2023 | 28.71% |
Ginkgo Bioworks (DNA) | 12/13/2023 - 12/20/2023 | 27.82% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
